Please login to the form below

Not currently logged in

NICE backs Boehringer's blood clot treatment Pradaxa

Boehringer Ingelheim Pradaxa

Draft DVT and PE guidance puts it on course to catch up with Bayer's Xarelto

Cuts help Teva raise profits, despite flat sales

Teva Pharma logoEarnings attributed largely to firm’s generics business

BMS' PD-1 blocker Opdivo aces lung cancer trial

Bristol-Myers Squibb (BMS) building41% of treated patients alive after 12 months

Novo Nordisk profits up 4%, buoyed by Victoza and Levemir

Novo Nordisk headquartersBut expects net loss for 2014 from currency impact

Orphan drug market to reach $176bn by 2020

pharmacistNew report suggests market will almost double in five years

Bayer CEO Dekkers points to 'outstanding' pharma growth

Bayer symbolOn target to meet company’s annual expectations of €7.5bn

Boehringer and Lilly to restructure diabetes alliance

Lilly Boehringer diabetes collaborationSay revisions to the alliance will not affect the world's largest markets

Pfizer gets FDA nod for meningitis vaccine Trumenba

Pfizer headquartersAhead of Novartis’ rival drug Bexsero

AZ to work with UK university on drug delivery technologies

The University of ManchesterCompany's staff will also teach parts of courses at The University of Manchester

Genes on demandAltering genes on demand

New award-winning research techniques could revolutionise drug discovery

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company

eyeforpharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay...

Latest intelligence

Business in the USA
The pharma business environment in the US
Tighter regulations, more pricing controls and increased international competition will drive market improvements...
babylon virtual health service
VIDEO: Switching to a virtual health service
Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone...
Online Physician Communities
Is the pharma industry bad?
Surveys of doctors and the public suggest not...